7Baggers
 published on: 2025-11-12 03:37:04  newser.com Wed, 12 Nov 2025 09:37:04 GMT
 Cantor Fitzgerald reiterates Overweight rating on NeuroPace stock By Investing.com  Investing.com Australia Tue, 11 Nov 2025 00:44:05 GMT
 Cantor Fitzgerald reiterates Overweight rating on NeuroPace stock By Investing.com  Investing.com Nigeria Mon, 10 Nov 2025 16:44:54 GMT
 fy2025 eps estimates for neuropace raised by hc wainwright  MarketBeat Mon, 10 Nov 2025 06:55:51 GMT
 published on: 2025-11-10 00:14:08  newser.com Mon, 10 Nov 2025 06:14:08 GMT
 NeuroPace (NPCE) Q3 2025 Earnings Call Transcript  The Motley Fool Sun, 09 Nov 2025 05:14:00 GMT
 neuropace, inc. reports record revenue and growth  MSN Sat, 08 Nov 2025 18:21:23 GMT
 neuropace reports q3 eps (11c), consensus (19c)  MSN Sat, 08 Nov 2025 18:05:11 GMT
 NeuroPace FY2025 EPS Forecast Increased by Leerink Partnrs  MarketBeat Sat, 08 Nov 2025 12:25:33 GMT
 Cantor Fitzgerald Lifts Earnings Estimates for NeuroPace  MarketBeat Sat, 08 Nov 2025 12:25:28 GMT
 discipline and rules-based execution in npce response  news.stocktradersdaily.com Fri, 07 Nov 2025 21:38:03 GMT
 neuropace, inc. (nasdaq:npce) q3 2025 earnings call transcript  Insider Monkey Fri, 07 Nov 2025 02:45:26 GMT
 neuropace reports record revenue and raises guidance  MSN Thu, 06 Nov 2025 17:51:34 GMT
 u.s. epilepsy monitoring devices market to witness massive  openPR.com Thu, 06 Nov 2025 12:27:43 GMT
 neuropace, inc.'s (nasdaq:npce) p/s still appears to be reasonable  富途牛牛 Thu, 06 Nov 2025 12:19:49 GMT
 y intercept hong kong ltd takes position in neuropace, inc. $npce  MarketBeat Thu, 06 Nov 2025 08:28:56 GMT
 NeuroPace stock price target raised to $19 by Leerink on strong Q3 results  Investing.com Australia Thu, 06 Nov 2025 04:09:43 GMT
 JP Morgan Raises Price Target for NeuroPace (NPCE) to $18.00 | N  GuruFocus Thu, 06 Nov 2025 04:06:46 GMT
 NeuroPace stock rises as Cantor Fitzgerald reiterates Overweight rating  Investing.com India Thu, 06 Nov 2025 03:39:00 GMT
 NeuroPace, Inc. (NPCE) Reports Q3 Loss, Tops Revenue Estimates  sharewise.com Thu, 06 Nov 2025 01:56:01 GMT
 neuropace, inc. reports record revenue and growth  TipRanks Thu, 06 Nov 2025 01:32:41 GMT
 Neuropace earnings beat by $0.09, revenue topped estimates  Investing.com Australia Wed, 05 Nov 2025 18:31:57 GMT
 NeuroPace stock price target raised to $19 by Leerink on strong Q3 results  Investing.com India Wed, 05 Nov 2025 16:11:47 GMT
 NeuroPace revenue jumps 30% to USD 27.4M in Q3 2025  Medical Buyer Wed, 05 Nov 2025 11:49:27 GMT
 neuropace inc.: q3 earnings snapshot  CT Insider Wed, 05 Nov 2025 08:44:10 GMT
 NeuroPace, Inc. Reports Record Revenue and Growth  TipRanks Wed, 05 Nov 2025 08:00:00 GMT
 NeuroPace Reports Record Revenue and Raises Guidance  TipRanks Wed, 05 Nov 2025 06:10:28 GMT
 neuropace inc.: q3 earnings snapshot  San Francisco Chronicle Tue, 04 Nov 2025 22:39:57 GMT
 neuropace (npce) q3 2025 earnings call transcript  AOL.com Tue, 04 Nov 2025 21:30:00 GMT
 neuropace, inc. (npce) q3 fy2025 earnings call transcript  Yahoo Finance Tue, 04 Nov 2025 21:30:00 GMT
 NeuroPace's Q3 revenue beats estimates  MarketScreener Tue, 04 Nov 2025 21:24:30 GMT
 neuropace, inc. revises earnings guidance for the full year of 2025  MarketScreener Tue, 04 Nov 2025 21:05:00 GMT
 published on: 2025-11-04 02:38:39  newser.com Tue, 04 Nov 2025 08:38:39 GMT
 NeuroPace, Inc. (NPCE) Reports Q3 Loss, Tops Revenue Estimates  Yahoo Finance Tue, 04 Nov 2025 08:00:00 GMT
 Neuropace earnings beat by $0.09, revenue topped estimates  Investing.com Tue, 04 Nov 2025 08:00:00 GMT
 NeuroPace reports Q3 EPS (11c), consensus (19c)  TipRanks Tue, 04 Nov 2025 08:00:00 GMT
 neuropace, inc. (npce) analyst insights, price targets & recommendations  Yahoo! Finance Canada Tue, 04 Nov 2025 00:14:09 GMT
 published on: 2025-11-03 15:47:28  Fundação Cultural do Pará Mon, 03 Nov 2025 18:47:28 GMT
 NeuroPace Inc (NPCE) Q3 2025 Earnings Report Preview: What to Look For  Yahoo Finance Mon, 03 Nov 2025 08:00:00 GMT
 operating expenses (excl. cogs) of neuropace, inc. – boats:npce  TradingView Sun, 02 Nov 2025 07:32:57 GMT

NeuroPace Inc
(NASDAQ:NPCE) 

NPCE stock logo

Based in Mountain View, Calif., NeuroPace is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially av...

Founded: 1997
Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing

Share this website to your friends